Bioequivalence Study of Topiramate Tablets 25mg Under Fasting Conditions

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The objective of this study was to compare the single-dose relative bioavailability of Ranbaxy and Ortho-McNeil Pharmaceutical (Topamax®) 25 mg topiramate tablets following a 50 mg dose under fasting conditions.
Epistemonikos ID: bd653b73ac7df6147b239e75ff319f27626b49c8
First added on: May 05, 2024